Anti Diabetic Medicine
Prominent & Leading from Nagpur, we offer 10 mg dapasmart tablets dapagliflozin tablets, 1000 mg phage sr tablets metformin hcl sr tablets, 7 mg rybesules tablets semaglutide tablets, 1000 mg glycoheal tablets, 100 mg istavel tablets sitagliptin tablets and 500 mg biciphage tablets metformin hcl tablets.
10 mg Dapasmart Tablets Dapagliflozin Tablets
Request Callback
₹ 874 / Strip Get Latest Price
| Strength | 10 mg |
| Form | Tablets |
| Composition | Dapagliflozin 10 mg |
| Packaging Size | 1*10 |
| Packaging Type | Strip |
Minimum order quantity: 100 Strip
Dapagliflozin Tablets 10 mg are commonly used in combination with other antidiabetic medications such as metformin, saxagliptin, or insulin for the management of type 2 diabetes mellitus. Dapagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that helps lower blood glucose levels by promoting the excretion of glucose through urine. When combined with Metformin, it offers complementary mechanisms of action—metformin reduces hepatic glucose production, while dapagliflozin enhances renal glucose elimination, leading to improved glycemic control. In combination with Saxagliptin, a DPP-4 inhibitor, the therapy provides enhanced effects on both fasting and postprandial glucose levels. Additionally, dapagliflozin can be used with insulin or sulfonylureas, allowing better blood sugar regulation in patients inadequately controlled by monotherapy. These combinations also offer potential benefits such as modest weight loss and blood pressure reduction, though they require monitoring for side effects like urinary tract infections, dehydration, or hypoglycemia, especially when used with insulin or sulfonylureas.
1000 mg Phage SR Tablets Metformin HCL SR Tablets
Request Callback
₹ 897 / Strip Get Latest Price
| Strength | 1000 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Phage 1000 mg SR Tablets |
| Manufacturer | HAB |
| Shelf Life | 24 Months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Metformin HCl SR (Sustained Release) Tablets 1000 mg are commonly prescribed oral antidiabetic medications used in the management of type 2 diabetes mellitus. The sustained-release formulation allows for a gradual release of the active ingredient, Metformin hydrochloride, into the bloodstream, which helps maintain consistent blood glucose levels over an extended period, improving glycemic control and enhancing gastrointestinal tolerability. Metformin works primarily by decreasing hepatic glucose production, increasing insulin sensitivity, and enhancing peripheral glucose uptake and utilization. It is typically used alone or in combination with other antidiabetic agents such as sulfonylureas, DPP-4 inhibitors, or insulin, depending on the patient's glycemic needs. This formulation is especially beneficial for patients requiring high doses of Metformin, as it helps minimize gastrointestinal side effects like nausea and diarrhea often associated with the immediate-release form.
7 mg Rybesules Tablets Semaglutide Tablets
Request Callback
₹ 964 / Strip Get Latest Price
| Strength | 7 mg |
| Packaging size | 10*10 Tablets |
| Packaging Type | Strip |
| Brand | Rybesules 7 mg Tablets |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Semaglutide Tablets 7 mg are an oral antidiabetic medication containing semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist, often formulated with absorption-enhancing agents such as sodium N-[8-(2-hydroxybenzoyl)amino] caprylate (SNAC) to improve its bioavailability. This combination works by mimicking the action of the natural incretin hormone GLP-1, which stimulates insulin secretion, reduces glucagon release, slows gastric emptying, and promotes satiety, thereby helping to lower blood glucose levels and support weight management in adults with type 2 diabetes mellitus. It is typically used as part of a comprehensive treatment plan that includes diet and exercise, and may be prescribed alone or with other antidiabetic agents when adequate glycemic control is not achieved.
1000 mg Glycoheal Tablets
Request Callback
₹ 895 / Strip Get Latest Price
| Strength | 1000 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Glycoheal 1000 mg Tablets |
| Manufacturer | Healing Pharma |
| Shelf Life | 24 Months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Metformin 1000 mg tablets are commonly used in the management of type 2 diabetes mellitus, either alone or in combination with other antidiabetic agents such as sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, insulin, or GLP-1 receptor agonists. When combined, these agents work synergistically to improve glycemic control through complementary mechanisms: metformin primarily reduces hepatic glucose production and enhances insulin sensitivity, while other drugs may increase insulin secretion, reduce glucose absorption, or enhance urinary glucose excretion. Such combinations are tailored based on individual patient needs, aiming to optimize blood sugar levels while minimizing side effects and the risk of hypoglycemia.
100 mg Istavel Tablets Sitagliptin Tablets
Request Callback
₹ 850 / Strip Get Latest Price
| Dose/Strength | 100 mg |
| Packaging Size | 1*10 Tablets |
| Packaging Type | Stripe |
| Manufacturer | Sun Pharma |
| Usage/Application | Personal |
| Shelf Life | 24 months |
Minimum order quantity: 100 Strip
Sitagliptin Tablets 100 mg are oral antidiabetic medications used primarily in the management of type 2 diabetes mellitus. Sitagliptin belongs to a class of drugs known as DPP-4 (dipeptidyl peptidase-4) inhibitors. It works by increasing the levels of incretin hormones, which help regulate blood sugar by stimulating insulin release and decreasing glucagon levels in a glucose-dependent manner. Sitagliptin is often used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin when diet and exercise alone are insufficient to control blood glucose levels. It is generally well-tolerated and does not usually cause hypoglycemia when used alone.
500 mg Biciphage Tablets Metformin HCL Tablets
Request Callback
₹ 876 / Strip Get Latest Price
| Strength | 500 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Biciphage 500 mg Tablets |
| Manufacturer | Biochem |
| Shelf Life | 24 Months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Metformin HCL Tablets 500 mg are commonly used as a first-line treatment for type 2 diabetes mellitus. These tablets contain Metformin Hydrochloride, an oral antidiabetic agent belonging to the biguanide class, which works primarily by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and improving insulin sensitivity. Often prescribed alone or in combination with other antidiabetic medications such as sulfonylureas, DPP-4 inhibitors, or insulin, Metformin helps achieve better glycemic control without causing significant weight gain or hypoglycemia. It may also be used in conditions like polycystic ovary syndrome (PCOS) due to its beneficial effects on insulin resistance.
1000 mg Myformin Tablets Metformin PR HCL Tablets
Request Callback
₹ 976 / Strip Get Latest Price
| Strength | 1000 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Myformin 1000 mg Tablets |
| Manufacturer | Dr. Morepen |
| Shelf Life | 24 Months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Metformin PR (Prolonged Release) HCL 1000 mg Tablets are an oral antidiabetic medication used primarily for the management of type 2 diabetes mellitus. The formulation contains Metformin Hydrochloride in a prolonged-release form, which allows for a gradual and sustained release of the drug into the bloodstream, enhancing gastrointestinal tolerance and improving patient compliance by reducing dosing frequency. Metformin works by decreasing hepatic glucose production, reducing intestinal absorption of glucose, and enhancing insulin sensitivity, thereby improving glycemic control without causing significant weight gain or hypoglycemia. It is often used alone or in combination with other antidiabetic agents such as sulfonylureas, DPP-4 inhibitors, SGLT2 inhibitors, or insulin for optimal blood sugar management.
500 mg Biciphage Tablets (SR) Metformin HCL Tablets
Request Callback
₹ 893 / Strip Get Latest Price
| Strength | 500 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Biciphage 500 mg SR Tablets |
| Manufacturer | Biochem |
| Shelf Life | 24 Months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Metformin HCL (Sustained Release) Tablets 500 mg are commonly prescribed as a first-line treatment for type 2 diabetes mellitus, either alone or in combination with other antidiabetic agents such as sulfonylureas, DPP-4 inhibitors, or insulin. The sustained-release formulation allows for gradual release of the medication, helping to maintain stable blood glucose levels throughout the day while minimizing gastrointestinal side effects commonly associated with immediate-release forms. In combination therapies, Metformin SR enhances insulin sensitivity and reduces hepatic glucose production, thereby complementing the mechanisms of action of other drugs for improved glycemic control. This combination approach supports better long-term management of blood sugar levels, potentially reducing the risk of diabetes-related complications.
500 mg Metfor Tablets Metformin HCL Tablets
Request Callback
₹ 695 / Strip Get Latest Price
| Strength | 500 mg |
| Pack Size | 1*10 Tablet |
| Pack Type | Strip |
| Brand | Metfor Tablets |
| Manufacturer | Cipla |
| Shelf Life | 24 Months |
| Usage | To Treat Type 2 Diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Metformin HCL Tablets are commonly used in combination with other antidiabetic agents such as sulfonylureas (e.g., glipizide), DPP-4 inhibitors (e.g., sitagliptin), SGLT2 inhibitors (e.g., empagliflozin), or insulin to achieve better glycemic control in patients with type 2 diabetes mellitus. These combination therapies leverage metformin’s ability to reduce hepatic glucose production and improve insulin sensitivity, while the accompanying agents act through complementary mechanisms—such as enhancing insulin secretion, reducing glucose reabsorption in the kidneys, or increasing glucose uptake. This synergistic approach helps in achieving targeted blood sugar levels, minimizing the risk of hypoglycemia, and improving long-term metabolic outcomes
6 mg Lirafit Injection Liraglutide Injection
Request Callback
₹ 5986 / Piece Get Latest Price
| Dose/Strength | 6 mg/ml |
| Packaging Size | 3 ml |
| Packaging Type | Piece |
| Brand | Lirafit Injection |
| Usage/Application | Personal |
| Manufacturer | Glenmark |
| Shelf Life | 36 Months |
Minimum order quantity: 100 Piece
Liraglutide Injection 6 mg is a glucagon-like peptide-1 (GLP-1) receptor agonist used primarily in the management of type 2 diabetes mellitus and obesity. It may be combined with other antidiabetic agents such as metformin, sulfonylureas, or insulin to enhance glycemic control when monotherapy is insufficient. In such combinations, Liraglutide works synergistically by enhancing glucose-dependent insulin secretion, suppressing inappropriate glucagon release, slowing gastric emptying, and promoting satiety, thereby aiding in both blood sugar regulation and weight reduction. The combination therapy helps improve overall metabolic control and may reduce the risk of cardiovascular complications associated with diabetes.
100 mg Sitayes Tablets Sitagliptin Tablets
Request Callback
₹ 876 / Strip Get Latest Price
| Dose/Strength | 100 mg |
| Packaging Size | 1*10 Tablets |
| Packaging Type | Stripe |
| Manufacturer | Dr. Morepen |
| Usage/Application | Personal |
| Shelf Life | 24 Months |
Minimum order quantity: 100 Strip
Sitagliptin Tablets 100 mg are commonly used in combination with other antidiabetic agents, such as metformin, sulfonylureas, or insulin, to improve glycemic control in adults with type 2 diabetes mellitus. Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor, which works by increasing the levels of incretin hormones, thereby enhancing insulin secretion and decreasing glucagon levels in a glucose-dependent manner. When combined with metformin, it helps improve both fasting and postprandial blood glucose levels. This combination is particularly beneficial for patients who do not achieve adequate glycemic control with monotherapy. Sitagliptin-based combinations are generally well-tolerated, with a low risk of hypoglycemia and a neutral effect on body weight, making them a suitable option for long-term diabetes management.
100 IU/ ml Humalog Kwikpen Insulin Lispro
Request Callback
₹ 5986 / Piece Get Latest Price
| Dose/Strength | 100 I.u |
| Brand | Humalog Kwikpen |
| Packaging Size | 3 ml |
| Packaging Type | Pre-filled Pen |
| Manufacturer | Lilly |
| Usage/Application | Personal |
| Shelf Life | 24 Months |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Piece
Insulin Lispro KwikPen is a prefilled, disposable insulin delivery device designed for rapid-acting insulin therapy, typically used to manage blood glucose levels in people with diabetes. Insulin Lispro itself is a fast-acting analog of human insulin that begins to work within 15 minutes of injection, peaks in about 1–2 hours, and has a duration of action of 3–5 hours, making it suitable for controlling postprandial (after meal) blood sugar spikes. The KwikPen device allows for easy, accurate, and convenient dosing, featuring a dial to select the required units and a push-button mechanism for injection. It is often used in combination with longer-acting basal insulins as part of a comprehensive insulin regimen to achieve optimal glycemic control. The combination of rapid action and ease of administration makes Insulin Lispro KwikPen a preferred option for many patients who require flexible mealtime insulin dosing.
14 mg Rybesules Tablets Semaglutide Tablets
Request Callback
₹ 7859 / Strip Get Latest Price
| Strength | 14 mg |
| Packaging size | 30*10 Tablets |
| Packaging Type | Strip |
| Brand | Rybesules 14 mg Tablets |
| Manufacturer | Novo-Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
| Prescription / Non Prescription | Prescription |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Semaglutide 14 mg tablets are typically used in the management of type 2 diabetes mellitus and obesity. When combined with other antidiabetic agents such as metformin, SGLT2 inhibitors (like empagliflozin), or insulin, this combination works synergistically to improve glycemic control. Semaglutide, a GLP-1 receptor agonist, enhances glucose-dependent insulin secretion, suppresses inappropriate glucagon release, and slows gastric emptying, while the accompanying medications complement its effects through different mechanisms—metformin reducing hepatic glucose production, SGLT2 inhibitors promoting renal glucose excretion, and insulin directly lowering blood glucose. This combination not only helps achieve better blood sugar control but may also contribute to weight reduction and cardiovascular risk management in patients with type 2 diabetes.
3 mg Rybelsus Tablets Semaglutide Tablets
Request Callback
₹ 2879 / Strip Get Latest Price
| Strength | 3 mg |
| Packaging size | 10*10 Tablets |
| Packaging Type | Strip |
| Brand | Rybelsus Tablets |
| Manufacturer | Novo Nordisk |
| Shelf Life | 24 Months |
| Usuage | to treat type 2 diabetes |
| Prescription / Non Prescription | Prescription |
| Also gives | Pharmaceutical Third Party Manufacturing |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Semaglutide 3 mg Tablets are an oral formulation of semaglutide, a glucagon-like peptide-1 (GLP-1) receptor agonist used for the management of type 2 diabetes mellitus. This medicine works by stimulating insulin secretion in response to high blood glucose levels, reducing glucagon release, and slowing gastric emptying, which helps in improving glycemic control and promoting weight reduction. The 3 mg strength is generally prescribed as a starting dose to allow the body to adjust to the medication before gradually increasing to higher therapeutic doses. It is usually taken once daily with water, at least 30 minutes before the first meal, beverage, or other oral medicines of the day. Semaglutide tablets are often used in combination with diet, exercise, and sometimes other antidiabetic medications to achieve optimal blood sugar control and reduce the risk of diabetes-related complications.
10 mg Mounjaro Kwikpen Tirzepatide Pre-Filled Pen
Request Callback
₹ 32000 / Box Get Latest Price
| Strength | 10 mg |
| Packaging Size | 0.6 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 10 mg Kwikpen |
| Manufacturer | Lilly |
| Prescription | Yes |
| Usage / Application | Anti-Diabetic |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Box
Tirzepatide 10 mg Injection is an advanced antidiabetic medication that combines the dual action of a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a glucagon-like peptide-1 (GLP-1) receptor agonist in a single formulation. This unique combination enhances insulin secretion, improves insulin sensitivity, reduces glucagon release, and slows gastric emptying, thereby helping to control blood sugar levels effectively in patients with type 2 diabetes mellitus. Along with improving glycemic control, it also supports weight reduction and better metabolic outcomes, making it beneficial for patients with obesity and associated cardiovascular risks. It is administered subcutaneously once weekly under medical supervision as part of a comprehensive diabetes management plan that includes diet and exercise.
2.5 Mg Mounjaro Kwikpen Tirzepatide Pre-Filled Pen
Request Callback
₹ 19500 / Box Get Latest Price
| Strength | 2.5 mg |
| Packaging Size | 0.6 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 2.5 mg Kwikpen Injection |
| Manufacturer | Lilly |
| Prescription | Yes |
| Usage / Application | Anti-Diabetic |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Box
Tirzepatide Injection 2.5 mg is an advanced antidiabetic medication used for the management of type 2 diabetes mellitus, and it also shows benefits in weight management. It is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, which means it mimics the actions of these two incretin hormones to enhance insulin secretion, reduce glucagon levels, slow gastric emptying, and promote satiety. This dual action helps improve blood sugar control while also supporting weight reduction, making it a valuable option for patients requiring both glycemic control and metabolic benefits. Tirzepatide is administered as a once-weekly subcutaneous injection and is typically used along with diet and exercise, and sometimes in combination with other antidiabetic agents, under the guidance of a healthcare professional.
15 Mg Mounjaro Kwikpen Tirzepatide Pre-Filled Pen
Request Callback
₹ 38950 / Box Get Latest Price
| Strength | 15 mg |
| Packaging Size | 0.6 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 15 mg Kwikpen |
| Manufacturer | Lilly |
| Prescription | Yes |
| Usage / Application | Anti-Diabetic |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Box
Tirzepatide 15 mg Pre-Filled Kwikpen is an antidiabetic medication presented as an easy-to-use injectable device, designed for once-weekly administration. It combines the actions of a dual glucose-dependent insulinotropic polypeptide (GIP) receptor agonist and a glucagon-like peptide-1 (GLP-1) receptor agonist, offering a novel mechanism to improve glycemic control in adults with type 2 diabetes mellitus. By enhancing insulin secretion, reducing glucagon levels, slowing gastric emptying, and promoting satiety, Tirzepatide helps lower blood sugar levels and may also support weight reduction. The pre-filled Kwikpen ensures accurate dosing, convenience, and patient-friendly self-administration, making it a suitable option for individuals requiring long-term glycemic management.
2. 5mg Mounjaro Kwik Pen Tirzepatide Pre-Filled Pen
Request Callback
₹ 19500 / Vial Get Latest Price
| Packaging Size | 0.5 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 2.5 mg Kwik Pen |
| Manufacturer | Lilly |
| Prescription | Yes |
| Storage Conditions | Cold Storage |
| Strength | 2.5 mg |
Minimum order quantity: 100 Vial
Tirzepatide Injection 2.5 mg is a combination antidiabetic medication that acts as a dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, designed for subcutaneous administration. By mimicking the action of these incretin hormones, it enhances insulin secretion, reduces glucagon release, slows gastric emptying, and promotes satiety, thereby helping to lower blood glucose levels and support weight management in adults with type 2 diabetes mellitus. This combination mechanism offers improved glycemic control and potential cardiovascular and metabolic benefits when used alongside diet and exercise, and it may be prescribed alone or with other antidiabetic agents depending on the patient’s treatment needs.
12.5 mg Mounjaro Kwikpen Tirzepatide Pre-Filled Kwikpen
Request Callback
₹ 31000 / Box Get Latest Price
| Strength | 12.5 mg |
| Packaging Size | 0.6 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 12.5 mg Kwikpen |
| Manufacturer | Lilly |
| Prescription | Yes |
| Usage / Application | Anti-Diabetic |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Box
Tirzepatide 12.5 mg Pre-Filled Kwikpen is an antidiabetic injectable medication that combines dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist activity in a single formulation. This innovative combination works synergistically to enhance insulin secretion, reduce glucagon release, slow gastric emptying, and promote satiety, thereby helping to improve glycemic control and support weight reduction in adults with type 2 diabetes mellitus. Supplied in a convenient pre-filled Kwikpen for subcutaneous administration, it allows accurate dosing and ease of self-injection. Tirzepatide is generally prescribed as part of a comprehensive diabetes management plan that includes diet, exercise, and lifestyle modifications, offering significant benefits for blood sugar regulation and metabolic health.
25 mg Jardiance Tablets Empagliflozin Tablets
Request Callback
₹ 895 / Strip Get Latest Price
| Strength | 25 mg |
| Composition | Empagliflozin 25 mg Tablets |
| Form | Tablets |
| Packaging Size | 1*10 |
| Packaging Type | Strip |
| Country of Origin | Made in India |
Minimum order quantity: 100 Strip
Empagliflozin Tablets 25 mg are commonly used in combination with other antidiabetic agents such as Metformin, Linagliptin, or Sitagliptin to improve glycemic control in adults with type 2 diabetes mellitus. Empagliflozin is a sodium-glucose co-transporter-2 (SGLT2) inhibitor that works by reducing glucose reabsorption in the kidneys, leading to increased urinary glucose excretion. When combined with Metformin, a biguanide that decreases hepatic glucose production and increases insulin sensitivity, or Linagliptin/Sitagliptin, which are DPP-4 inhibitors that enhance incretin activity, the combination offers a complementary mechanism of action to lower blood sugar levels effectively. These fixed-dose combinations may also contribute to additional benefits such as weight reduction and modest blood pressure lowering. They are typically indicated when monotherapy does not provide adequate glycemic control.
850 mg Glycoheal Tablets Metformin HCL Tablets
Request Callback
₹ 987 / Strip Get Latest Price
| Strength | 850 mg |
| Release Form | Immediate |
| Pack Size | 10 tablets |
| Brand | Glycoheal |
| Prescription | Prescription |
| Form | Tablet |
| Packaging Type | Blister |
| Usage | Type 2 Diabetes |
| Shelf Life | 24 months |
Minimum order quantity: 100 Strip
Metformin HCl 850 mg tablets are an oral antidiabetic medication primarily used in the management of type 2 diabetes mellitus. They work by lowering blood glucose levels through decreasing glucose production in the liver, reducing intestinal absorption of glucose, and improving the body’s sensitivity to insulin. This helps the body use insulin more effectively without causing excessive insulin release. Metformin is commonly prescribed as a first-line therapy and may be used alone or in combination with other antidiabetic medicines. The 850 mg strength is often chosen for patients who require moderate to higher dosing for effective glycemic control. Metformin HCl tablets are generally well tolerated, with gastrointestinal effects such as nausea, diarrhea, or abdominal discomfort being the most common side effects, especially at the start of therapy.
25 mg Emsafe Tablets Empagliflozin Tablets
Request Callback
₹ 698 / Strip Get Latest Price
| Strength | 25 mg |
| Composition | Empagliflozin |
| Pack Size | 10 tablets |
| Brand | Emsafe |
| Usage | Type 2 Diabetes |
| Prescription Type | Rx Only |
| Origin | Indian |
| Shelf Life | 36 months |
Minimum order quantity: 100 Strip
Empagliflozin 25 mg tablets are an oral antidiabetic medication used primarily for the management of type 2 diabetes mellitus. They belong to the class of drugs known as sodium–glucose co-transporter-2 (SGLT2) inhibitors and work by reducing glucose reabsorption in the kidneys, thereby increasing the excretion of excess glucose through urine. This helps lower blood sugar levels and also contributes to modest weight loss and blood pressure reduction. Empagliflozin 25 mg is typically prescribed once daily and may be used alone or in combination with other antidiabetic agents. In addition to glycemic control, it has proven cardiovascular and renal benefits, including reduced risk of heart failure hospitalization and slowing the progression of kidney disease in eligible patients.
All Star Insulin Pen (Reusable)
Request Callback
₹ 2547 / Piece Get Latest Price
| Pen Type | Reusable Pen |
| Cartridge Size | 3 ml |
| Compatible Insulin | All-Star |
| Usage | Type 1 Diabetes, Type 2 Diabetes |
| Body Material | Plastic |
| Colour | Blue |
| Packaging Type | Single Pen |
Minimum order quantity: 100 Piece
The All Star Insulin Pen is a reusable insulin delivery device designed to provide accurate, convenient, and comfortable insulin administration for people with diabetes. It features a sturdy, ergonomic design that ensures easy handling and precise dose selection, helping users maintain better glycemic control. The pen is compatible with standard insulin cartridges and offers a smooth injection mechanism with clear dose markings for added confidence and safety. Durable and easy to use, the All Star Insulin Pen is suitable for daily diabetes management, supporting consistent and reliable insulin delivery
10 mg Jardiance Tablets Empagliflozin Tablets
Request Callback
₹ 1954 / Strip Get Latest Price
| Strength | 10 mg |
| Composition | Empagliflozin |
| Pack Size | 10 tablets |
| Brand | Jardiance |
| Usage | Type 2 Diabetes, Heart Failure |
| Prescription Type | Rx Only |
| Origin | Imported |
| Shelf Life | 36 months |
Minimum order quantity: 100 Strip
Empagliflozin 10 mg tablets are an oral medication primarily used to manage type 2 diabetes mellitus. Belonging to the class of drugs called SGLT2 (sodium-glucose co-transporter 2) inhibitors, these tablets work by preventing the kidneys from reabsorbing glucose back into the blood, thereby promoting its excretion through urine and helping to lower blood sugar levels. Empagliflozin 10 mg is typically prescribed alongside diet and exercise to improve glycemic control and may also offer cardiovascular benefits, including a reduced risk of heart failure in patients with type 2 diabetes. The tablets are generally taken once daily, with or without food, and patients are advised to stay hydrated and monitor for potential side effects such as urinary tract infections, increased urination, or dizziness due to lowered blood pressure.
100 mg Sitasmart Tablets Sitagliptin Tablets
Request Callback
₹ 594 / Strip Get Latest Price
| Strength | 100 mg |
| Composition | Sitagliptin |
| Pack Size | 10 tablets |
| Brand | Sitasmart |
| Release Type | Immediate Release |
| Usage | Type 2 Diabetes |
| Sugar Status | Sugar Free |
| Shelf Life | 24 months |
Minimum order quantity: 100 Strip
Sitagliptin 100 mg tablets are an oral antidiabetic medication used in the management of type 2 diabetes mellitus. They work by inhibiting the dipeptidyl peptidase-4 (DPP-4) enzyme, which increases the levels of incretin hormones in the body, thereby enhancing insulin secretion in a glucose-dependent manner and reducing the release of glucagon. This dual action helps lower both fasting and post-meal blood glucose levels without causing significant hypoglycemia when used alone. Sitagliptin 100 mg is typically taken once daily, with or without food, and may be used as monotherapy or in combination with other antidiabetic agents such as metformin, sulfonylureas, or insulin. It is generally well tolerated and does not usually cause weight gain when taken as prescribed.
100 IU Novo-Rapid Flex Pen Insulin Aspart
Request Callback
₹ 3957 / Piece Get Latest Price
| Pen Type | Disposable Pen |
| Cartridge Size | 3 ml |
| Compatible Insulin | Novorapid |
| Dose Increment | 1 unit step |
| Brand | Novo Nordisk |
| Usage | Type 2 Diabetes, Type 1 Diabetes |
| Body Material | Plastic |
| Colour | Blue |
| Packaging Type | Single Pen |
Minimum order quantity: 100 Piece
Insulin Aspart 100 IU Pen is a rapid-acting insulin analog used to control high blood sugar levels in people with diabetes mellitus. It is designed to mimic the body’s natural insulin response after meals, helping to regulate postprandial glucose spikes. The insulin is administered subcutaneously using a prefilled pen device, which allows for accurate dosing and convenient self-administration. Onset of action typically occurs within 10–20 minutes, with peak activity around 1–3 hours and a duration of up to 5 hours, making it suitable for mealtime glucose management. Insulin Aspart 100 IU Pen should be used under medical supervision, and doses must be individualized based on blood glucose monitoring, diet, and physical activity.
10 mg Empagreat Tablets Empagliflozin Tablets
Request Callback
₹ 584 / Strip Get Latest Price
| Strength | 10 mg |
| Composition | Empagliflozin |
| Pack Size | 10 tablets |
| Brand | Empagreat |
| Usage | Heart Failure, Type 2 Diabetes |
| Origin | Indian |
| Shelf Life | 36 months |
Minimum order quantity: 100 Strip
Empagliflozin 10 mg tablets are an oral antidiabetic medication used to improve glycemic control in adults with type 2 diabetes mellitus. It belongs to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors and works by reducing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine. In addition to lowering blood sugar levels, empagliflozin has been shown to provide cardiovascular and renal benefits, including reducing the risk of heart-related death in patients with diabetes and established cardiovascular disease. It is typically used alongside diet and exercise and may be prescribed alone or in combination with other antidiabetic agents. Common side effects may include urinary tract infections, increased urination, and dehydration, and it should be used under medical supervision.
25 mg Empagreat Tablets Empagliflozin Tablets
Request Callback
₹ 794 / Strip Get Latest Price
| Strength | 25 mg |
| Composition | Empagliflozin |
| Pack Size | 10 tablets |
| Brand | Empgreat |
| Usage | Heart Failure, Type 2 Diabetes |
| Origin | Indian |
| Shelf Life | 36 months |
Minimum order quantity: 100 Strip
Empagliflozin 25 mg tablets are an oral antidiabetic medication belonging to the class of SGLT2 (sodium-glucose co-transporter 2) inhibitors, used to improve glycemic control in adults with type 2 diabetes mellitus. It works by preventing glucose reabsorption in the kidneys, allowing excess sugar to be excreted through urine, thereby lowering blood glucose levels. In addition to its blood sugar–reducing effect, empagliflozin has been shown to provide cardiovascular and renal benefits, including reducing the risk of cardiovascular death in patients with diabetes and established heart disease. The tablets are typically taken once daily, with or without food, and are recommended alongside diet and exercise as part of a comprehensive diabetes management plan. Common side effects may include urinary tract infections, increased urination, and dehydration, and it should be used under medical supervision.
0.5 mg Weight Loss Semaglutide Injection
Request Callback
₹ 22478 / Piece Get Latest Price
| Composition | Semaglutide 0.5 mg Tablets |
| Strength | 0.5 mg |
| Form | Pre-filled Pen |
| Pack Size | 1.5 ml |
| Brand | Novo Nordisk |
| Usage | Type 1 Diabetes, Type 2 Diabetes |
| Storage Temp | 2-8 deg C |
| Onset Profile | Long Acting |
| Shelf Life | 24 months |
Minimum order quantity: 100 Piece
Semaglutide 0.5 mg injection is a prescription medication used primarily for the management of type 2 diabetes mellitus and, in some cases, for weight management in adults. It belongs to a class of drugs known as GLP-1 (glucagon-like peptide-1) receptor agonists, which work by stimulating insulin secretion in response to high blood sugar levels, reducing glucagon release, slowing gastric emptying, and promoting a feeling of fullness. Administered as a subcutaneous injection, typically once weekly, Semaglutide 0.5 mg helps improve glycemic control, supports weight loss, and reduces the risk of diabetes-related complications when used alongside diet and exercise. Patients should follow dosing instructions carefully and consult their healthcare provider for monitoring and potential side effects, which may include nausea, vomiting, diarrhea, or, in rare cases, more serious effects like pancreatitis.
0.25 mg Weight Loss Semaglutide Injection
Request Callback
₹ 18449 / Piece Get Latest Price
| Composition | Semaglutide |
| Strength | 0.25 mg |
| Form | Pre-filled Pen |
| Pack Size | 1.5 ml |
| Brand | Novo Nordisk |
| Usage | Type 1 Diabetes, Type 2 Diabetes |
| Storage Temp | 2-8 deg C |
| Onset Profile | Long Acting |
| Shelf Life | 24 months |
Minimum order quantity: 100 Piece
Semaglutide 0.25 mg injection is a prescription medication primarily used for the management of type 2 diabetes and, in some cases, for weight management under medical supervision. It belongs to a class of drugs called GLP-1 receptor agonists, which work by mimicking the action of the naturally occurring hormone GLP-1 (glucagon-like peptide-1) in the body. This helps to regulate blood sugar levels by stimulating insulin release in response to meals, reducing glucagon secretion, slowing gastric emptying, and promoting a feeling of fullness, which may aid in weight control. The 0.25 mg dose is typically the initial starting dose to minimize gastrointestinal side effects, such as nausea or vomiting, and is usually gradually increased based on the patient’s tolerance and therapeutic response. Semaglutide is administered subcutaneously, usually once weekly, and should be used in conjunction with a proper diet and exercise program as advised by a healthcare professional.
1 mg Weight Loss Injection Semaglutide Injection
Request Callback
₹ 25849 / Piece Get Latest Price
| Composition | Semaglutide |
| Strength | 1 mg |
| Form | Pre-filled Pen |
| Pack Size | 1.5 ml |
| Brand | Novo Nordisk |
| Usage | Type 2 Diabetes, Type 1 Diabetes |
| Storage Temp | 2-8 deg C |
| Onset Profile | Long Acting |
| Shelf Life | 24 months |
Minimum order quantity: 100 Piece
Semaglutide 1 mg injection is a prescription medication primarily used to improve blood sugar control in adults with type 2 diabetes, often in combination with diet and exercise. It belongs to a class of drugs called GLP-1 receptor agonists, which work by stimulating insulin release from the pancreas when blood sugar levels are high, while also reducing the amount of glucose produced by the liver. Additionally, Semaglutide slows gastric emptying, helping to promote a feeling of fullness, which can support weight management. This once-weekly injectable therapy is typically administered subcutaneously and should be used under the guidance of a healthcare professional, with monitoring for potential side effects such as nausea, vomiting, or gastrointestinal discomfort. It is not indicated for use in individuals with type 1 diabetes or for the treatment of diabetic ketoacidosis.
7.5 mg Mounjaro Kwikpen Tirzepatide Pre-Filled Pen
Request Callback
₹ 30789 / Box Get Latest Price
| Strength | 7.5 mg |
| Packaging Size | 0.6 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 7.5 mg Kwikpen |
| Manufacturer | Lilly |
| Prescription | Yes |
| Usage / Application | Anti-Diabetic |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Box
Tirzepatide 7.5 mg Injection is an innovative dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, designed for the management of type 2 diabetes mellitus and weight control in certain patients. By stimulating both GIP and GLP-1 pathways, it enhances insulin secretion, reduces glucagon levels, slows gastric emptying, and promotes satiety, leading to improved glycemic control and weight reduction. This combination activity offers greater efficacy compared to traditional GLP-1 agonists alone, making it a novel option for patients requiring additional support in managing blood sugar levels and associated metabolic risks. It is administered once weekly as a subcutaneous injection under medical supervision.
5 Mg Mounjaro Kwikpen Tirzepatide Pre-Filled Pen
Request Callback
₹ 28463 / Box Get Latest Price
| Strength | 5 mg |
| Packaging Size | 0.6 ml |
| Packaging Type | Pre-filled pen |
| Brand | Mounjaro 5 mg Kwikpen |
| Manufacturer | Lilly |
| Prescription | Yes |
| Usage / Application | Anti-Diabetic |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Box
Tirzepatide Injection 5 mg is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist used in the management of type 2 diabetes mellitus and, in some cases, for weight management in obese or overweight individuals with related comorbidities. By combining the actions of GIP and GLP-1 receptor stimulation, tirzepatide enhances insulin secretion in a glucose-dependent manner, reduces glucagon release, delays gastric emptying, and promotes satiety, thereby improving glycemic control and supporting weight reduction. This unique combination effect helps in achieving better blood sugar regulation while also addressing cardiovascular and metabolic risk factors associated with diabetes. It is usually administered once weekly via subcutaneous injection as part of a comprehensive treatment plan that includes diet, exercise, and lifestyle modifications.
100 mg Sitaglivac Tablets Sitagliptin Tablets
Request Callback
₹ 874 / Strip Get Latest Price
| Dose/Strength | 100 mg |
| Packaging Size | 1*7 |
| Packaging Type | Stripe |
| Manufacturer | Prevego |
| Usage/Application | Personal |
| Shelf Life | 24 Months |
Minimum order quantity: 100 Strip
Sitagliptin 100 mg tablets are an oral antidiabetic medication commonly used in combination with other agents to improve blood glucose control in patients with type 2 diabetes mellitus. Sitagliptin belongs to the class of dipeptidyl peptidase-4 (DPP-4) inhibitors, which work by enhancing the body’s natural incretin hormones, leading to increased insulin release and decreased glucagon levels in a glucose-dependent manner. When used in combination therapy, sitagliptin is often paired with metformin, sulfonylureas, thiazolidinediones, or insulin to achieve better glycemic control. This combination approach helps to target different mechanisms of blood sugar regulation, improving efficacy while potentially reducing the risk of side effects such as hypoglycemia. Sitagliptin is generally well-tolerated and offers the convenience of once-daily dosing, making it a versatile option in the management of type 2 diabetes.
5 mg Dapasmart Tablets Dapagliflozin Tablets
Request Callback
₹ 876 / Strip Get Latest Price
| Strength | 5 mg |
| Form | Tablets |
| Composition | Dapagliflozin 5 mg Tablets |
| Packaging Size | 1*10 |
| Packaging Type | Strip |
Minimum order quantity: 100 Strip
Dapagliflozin Tablets 5 mg are a prescription medication used primarily for the management of type 2 diabetes mellitus. Belonging to the class of sodium-glucose co-transporter 2 (SGLT2) inhibitors, dapagliflozin works by reducing glucose reabsorption in the kidneys, leading to increased urinary glucose excretion and improved glycemic control. In combination with diet and exercise, it helps lower blood sugar levels in adults, and may also be used alongside other antidiabetic agents such as metformin, sulfonylureas, or insulin for enhanced efficacy. Additionally, dapagliflozin provides cardiovascular and renal protective benefits, making it useful in patients with heart failure or chronic kidney disease. Regular monitoring of renal function and hydration status is advised during treatment.
2.5 mg Mounjaro Injection Tizrepatide Injection
Request Callback
₹ 7936 / Vial Get Latest Price
| Strength | 2.5 mg |
| Packaging Size | 0.5 ml |
| Packaging Type | Injection |
| Brand | Mounjaro 2.5 mg Injection |
| Manufacturer | Lilly |
| Prescription | Yes |
| Storage Conditions | Cold Storage |
Minimum order quantity: 100 Vial
Tirzepatide Injection 2.5 mg is a combination medication used primarily for the treatment of type 2 diabetes mellitus. It is a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This unique mechanism enhances glucose-dependent insulin secretion, suppresses glucagon levels, and slows gastric emptying, which collectively contribute to improved glycemic control and reduced appetite. Tirzepatide is administered as a once-weekly subcutaneous injection and is often used alongside diet and exercise to achieve optimal blood sugar management. In addition to its antidiabetic benefits, it has also shown promise in supporting weight loss in overweight or obese individuals with or without diabetes.
10 mg Semaglutide Injection
Request Callback
₹ 1543 / Piece Get Latest Price
| Packaging Type | Prefilled Pen |
| Brand | Semaglutide 10 mg Injection |
| Country of Origin | Made in India |
Minimum order quantity: 100 Piece
Semaglutide Injection 10 mg is a medication belonging to the class of glucagon-like peptide-1 (GLP-1) receptor agonists, used primarily for the management of type 2 diabetes mellitus and, in some cases, for chronic weight management. It works by mimicking the action of the natural hormone GLP-1, which increases insulin secretion in response to elevated blood glucose, suppresses excessive glucagon release, and slows gastric emptying, thereby helping to improve blood sugar control and promote satiety. The injection is typically administered subcutaneously once weekly, offering sustained blood glucose regulation and potential weight reduction benefits when combined with a healthy diet and regular exercise
8 mg Semanize Injection Semaglutide Injection
Request Callback
₹ 1693 / Piece Get Latest Price
| Dose/Strength | 8 mg/ml |
| Packaging Size | 1.5 ml |
| Packaging Type | Piece |
| Brand | Semanize 8 mg Injection |
| Usage/Application | Personal |
| Manufacturer | Bionize |
| Shelf Life | 20 months |
Minimum order quantity: 100 Piece
Semaglutide Injection 8 mg is a medication primarily used for the management of type 2 diabetes mellitus and, in some cases, for weight management in adults with obesity or overweight conditions accompanied by related health risks. It belongs to the class of GLP-1 (glucagon-like peptide-1) receptor agonists, which mimic the natural hormone GLP-1 to stimulate insulin secretion, reduce glucagon release, slow gastric emptying, and promote a feeling of fullness, thereby helping control blood sugar levels and support weight loss. The injection is typically administered subcutaneously once a week and may be used alone or in combination with other antidiabetic medicines such as metformin, sulfonylureas, or insulin, depending on the patient’s treatment needs and physician’s guidance.
50/1000 Sitasmart-M Tablets Sitagliptin & Metformin Tablets
Request Callback
₹ 694 / Strip Get Latest Price
| Strength | 50 mg/1000 mg |
| Packaging Size | 1*10 Tablets |
| Brand | Sitasmart-M 50/1000 tablets |
| Manufacturer | Healing Pharma |
| Usage/Application | Diabetic Patients |
| Shelf Life | 2 years |
Minimum order quantity: 100 Strip
Sitagliptin 50 mg and Metformin 1000 mg tablets are a combination oral antidiabetic medication used to manage type 2 diabetes mellitus. Sitagliptin is a DPP-4 (dipeptidyl peptidase-4) inhibitor that works by increasing the levels of incretin hormones, which help regulate blood glucose by stimulating insulin release and decreasing glucagon levels in a glucose-dependent manner. Metformin, a biguanide, improves insulin sensitivity and reduces hepatic glucose production, thereby lowering fasting and postprandial blood sugar levels. This combination provides complementary mechanisms of action to effectively control blood glucose in patients with type 2 diabetes, especially when diet, exercise, and monotherapy are insufficient. It is typically taken once or twice daily with meals to minimize gastrointestinal side effects associated with metformin.
50 mg / 1000 mg Sitayes M tablets Sitagliptin & Metformin Tablets
Request Callback
₹ 746 / Strip Get Latest Price
| Metformin Strength | 1000 mg |
| Sitagliptin Strength | 50 mg |
| Release Type | Immediate |
| Brand | Dr.Morepen |
| Packing Type | Blister |
| Tablets Per Strip | 10 tablets |
| Prescription | Prescription |
| Form | Tablet |
| Shelf Life | 24 months |
| Country Of Origin | India |
Minimum order quantity: 100 Strip
Sitagliptin 50 mg & Metformin 1000 mg tablets are a combination oral medication used to manage type 2 diabetes mellitus. Sitagliptin is a dipeptidyl peptidase-4 (DPP-4) inhibitor that helps regulate blood sugar levels by enhancing the body’s own ability to lower elevated glucose, primarily by increasing insulin release in response to meals and reducing the production of glucagon. Metformin, on the other hand, is a biguanide that works by decreasing hepatic glucose production, improving insulin sensitivity, and promoting peripheral glucose uptake. Together, this combination helps achieve better glycemic control in patients whose blood sugar levels are not adequately managed with diet, exercise, or either drug alone. It is usually prescribed alongside lifestyle modifications and should be taken under medical supervision, as it may have side effects such as gastrointestinal discomfort, lactic acidosis (rare), or hypoglycemia when combined with other antidiabetic agents.
X
Contact Us
Aayush Hariyani (CEO)
Balaji Healthline
Plot No 156, Near Fairdeal Arcade, Main Bazar Road, Jaripatka
Nagpur - 440014, Maharashtra, India
Send Email